Delayed scrutiny: Reported problems with birth control device expose gaps in FDA post-market surveillance.
Sabriya
S
Rice
D003267:Contraception / Q000295:instrumentation*; D057052:Medical Device Recalls; D011358:Product Surveillance, Postmarketing / Q000592:standards*; D014481:United States; D014486:United States Food and Drug Administration